Author

A. Brandao

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1

Frequent Co-Authors

A. M. Silva· 2 shared A. Miranda· 2 shared A. Peixoto· 2 shared C. Gaiteiro· 2 shared C. Palmeira· 2 shared D. Ferreira· 2 shared J. A. Ferreira· 2 shared J. Soares· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A. M. Silva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells

A. Peixoto, D. Ferreira, A. Miranda, M. Relvas-Santos, R. Freitas, T. S. Veth, A. Brandao, E. Ferreira, P. Paulo, M. Cardoso, C. Gaiteiro, S. Cotton, J. Soares, L. Lima, F. Teixeira, , J. A. Ferreira

This study identifies hypoxia and glucose deprivation as drivers of aggressiveness in bladder cancer through metabolic adaptation and altered glycosylation.

bioRxiv · Oct 21, 2023Biochemistry

Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion

c. gaiteiro, J. Soares, M. Relvas Santos, A. Peixoto, D. Ferreira, A. Brandao, E. Fernandes, R. Azevedo, P. Paulo, C. Palmeira, L. Lima, R. Freitas, A. Miranda, H. Osorio, A. M. Silva, , J. A. Ferreira

This study identifies CD44s as a biomarker of poor prognosis in bladder cancer and demonstrates the utility of glycoproteogenomics for characterizing splicing and glycosylation patterns linked to cancer invasion.

bioRxiv · Sep 4, 2021 · PreprintCancer Biology